The efficacy of curcumin in relieving osteoarthritis: A meta‐analysis of meta‐analyses

Abstract

Osteoarthritis (OA) is one of the most prevalent degenerative joint diseases. Several meta‐analyses have shown that curcumin could improve the function of the knee and alleviate pain in OA, while some meta‐analyses demonstrate controversial results. Hence, we assessed curcumin's effects on knee OA in an umbrella meta‐analysis. PubMed, Scopus, Embase, and Web of Science databases were employed to find English‐language meta‐analyses of randomized controlled trials investigating the effect of curcumin supplementation on OA outcomes up to September 2023. The visual analog scale (VAS), Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain, function, and stiffness scales were analyzed. Effect sizes and 95% confidence intervals were utilized to obtain the overall effect size. A random‐effects model was applied to perform the meta‐analysis. Heterogeneity was determined by I2 statistics and the Cochrane Q‐test. The pooled effect of the 11 included meta‐analyses showed that curcumin could significantly decrease the VAS score (weighted mean difference [WMD] and standardized mean difference [SMD]), WOMAC‐total (SMD and WMD), WOMAC‐Function (SMD and WMD), WOMAC‐Pain (SMD), and WOMAC‐Stiffness scores (SMD) (p ≤ 0.001, ≤0.001, ≤0.001, 0.007, ≤0.001, 0.002, ≤0.001, ≤0.001, respectively). The results strongly support curcuminoid supplementation in relieving pain, improving joint mobility and stiffness, and shortening medication usage of OA patients.